- Benzinga•2 days ago
The Vetr crowd upgraded their rating for Jazz Pharmaceuticals plc (NASDAQ: JAZZ ) on Thursday, from 3 stars (Hold), issued two days ago, to 4 stars (Buy). At the time of the upgrade, crowd sentiment for ...
- Zacks•3 days ago
Jazz Pharmaceuticals plc (JAZZ) is scheduled to report fourth-quarter 2016 results on Feb 28 after the market closes.
- PR Newswire•11 days agoJazz Pharmaceuticals to Report 2016 Fourth Quarter and Full Year Financial Results on February 28, 2017
DUBLIN, Feb. 14, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 fourth quarter and full year financial results on Tuesday, February 28, 2017, ...
JAZZ : Summary for Jazz Pharmaceuticals plc - Ordi - Yahoo Finance
Jazz Pharmaceuticals Public Limited Company (JAZZ)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||103.07 x 100|
|Day's Range||133.29 - 136.18|
|52 Week Range||95.80 - 160.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.80|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|